webleads-tracker

Home  >  MEDTECH  > Oxford Nanopore announces £40 million ($64 million) fundrai...
  >  MEDTECH
Oct 9th, 2013
 
Oxford Nanopore announces £40 million ($64 million) fundraising
 
Oxford Nanopore Technologies Ltd, the UK-based technology company specialising in nanopore-based electronic molecular analysis systems, has raised £40 million in new funding through a private placement of ordinary shares.
Send to a friend

The investment was received from new and existing investors in the US, UK and mainland Europe.  New investors include Odey Asset Management.

Funds will be used to further develop the Company's commercial and manufacturing infrastructure, continue innovative research and development in nanopore sensing and for various corporate objectives including the building and defence of the Company's broad intellectual property portfolio.

This transaction brings the total funds raised by Oxford Nanopore since its foundation in 2005 to £145 million.

Note: The placement of ordinary shares in the Company under this fundraising does not constitute an offer of the Company’s shares to the public.  No shares in the Company will be offered or sold to any person except in circumstances which have not resulted and will not result in an offer to the public.
 
About Oxford Nanopore
Oxford Nanopore Technologies® is developing a new generation of nanopore-based electronic systems for analysis of single molecules including DNA, RNA and proteins.  The GridION™ system and miniaturised MinION™ device are designed  to provide novel qualities in molecular sensing such as real-time data streaming, improved simplicity, efficiency and scalability of workflows and direct analysis of the molecule of interest .  The devices may be used use in scientific research, personalised medicine, crop science, security & defence and environmental applications.

Oxford Nanopore has licensed or owns more than 350 patents and patent applications that relate to many aspects of nanopore sensing from protein nanopores to solid state nanopores and for the analysis of DNA, proteins and other molecules. This includes the use of functionalised solid-state nanopores for molecular characterisation, methods of fabricating solid-state nanopores and modifications of solid-state nanopores to adjust sensitivity or other parameters.


 
More MEDTECH news

Aug 21st
Aug 21st
Aug 21st
Aug 13th
Jul 30th
 
©2007 Yole Developpement All rights reserved                  Disclaimer | Legal notice | To advertise
Yole Développement: Le Quartz, 75 cours Emile Zola, 69100 Villeurbanne, France. TEL: (33) 472 83 01 80 FAX: (33) 472 83 01 83 E-Mail: info @yole.fr